Cresco Labs Inc. CL.CN · Stock Open Cresco Labs Inc. in new tab
Analyst price targets
Recent rating changes, newest first
Cresco Labs Inc. Analysis (CL.CN)
Is Cresco Labs Inc. a good investment? Cresco Labs Inc. (CL.CN) is currently trading at 0.9000 CAD. Market analysts have a consensus price target of 2.58 CAD. This suggests a potential upside from current levels.
Earnings Schedule: Cresco Labs Inc. is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is -0.06.
Investor FAQ
Does Cresco Labs Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Cresco Labs Inc.?
Cresco Labs Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of -0.39.
Company Profile
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 3, 2018 | 0.00123057 |
Community Discussion